Innovative Insulin Pumps Drive Optimism for Tandem, Beta Bionics
William Blair initiated coverage on Tandem Diabetes Care and Beta Bionics, noting both companies are advancing initiatives to compete in faster-growing segments of the insulin pump market.
Why it matters — The analyst initiation highlights Tandem's efforts in faster-growing insulin pump segments, which could draw attention to its competitive positioning.